Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Greenberg

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Israel Journal of Health Policy Research|February 19, 2024
Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in IsraelOmer Ben-Aharon, Ruslan Sergienko, Georgi Iskrov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2017
Trajectories of Injectable Cancer Drug Costs After Launch in the United StatesNoa Gordon, Salomon M Stemmer, Dan Greenberg, et al.
International Journal of Health Policy and Management|October 12, 2021
Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?Ruth Waitzberg, Nora Gottlieb, Wilm Quentin, et al.
Harefuah|May 23, 2017
[HEALTH SCARES: A CHRONICLE UNNECESSARY ANXIETY]Iftach Sagy, Dan Greenberg, Alan Jotkowitz, et al.
Israel Journal of Health Policy Research|February 16, 2022
It probably worked: a Bayesian approach to evaluating the introduction of activity-based hospital payment in IsraelRuth Waitzberg, Martin Siegel, Wilm Quentin, et al.
Value in Health Regional Issues|May 22, 2019
What Is the Value of Innovative Pharmaceutical Therapies in Oncology and Hematology? A Willingness-to-Pay Study in BulgariaGeorgi Iskrov, Dan Greenberg, Ivan Yakimov, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Cost-utility analyses of diagnostic laboratory tests: a systematic reviewChiHui Fang, Hansel J Otero, Dan Greenberg, et al.
Health Policy (Amsterdam, Netherlands)|September 15, 2004
Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation studyDan Greenberg, Ameet Bakhai, Peter J Neumann, et al.
Angiology|February 28, 2020
Early Atrial Fibrillation During Acute Myocardial Infarction May Not Be an Indication for Long-Term AnticoagulationMichal Axelrod, Harel Gilutz, Ygal Plakht, et al.
ESC Heart Failure|November 8, 2021
The impact of a community-based heart failure multidisciplinary team clinic on healthcare utilization and costsJean Marc Weinstein, Dan Greenberg, Amir Sharf, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Israel Journal of Health Policy Research|February 19, 2024
Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in IsraelOmer Ben-Aharon, Ruslan Sergienko, Georgi Iskrov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2017
Trajectories of Injectable Cancer Drug Costs After Launch in the United StatesNoa Gordon, Salomon M Stemmer, Dan Greenberg, et al.
International Journal of Health Policy and Management|October 12, 2021
Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?Ruth Waitzberg, Nora Gottlieb, Wilm Quentin, et al.
Harefuah|May 23, 2017
[HEALTH SCARES: A CHRONICLE UNNECESSARY ANXIETY]Iftach Sagy, Dan Greenberg, Alan Jotkowitz, et al.
Israel Journal of Health Policy Research|February 16, 2022
It probably worked: a Bayesian approach to evaluating the introduction of activity-based hospital payment in IsraelRuth Waitzberg, Martin Siegel, Wilm Quentin, et al.
Value in Health Regional Issues|May 22, 2019
What Is the Value of Innovative Pharmaceutical Therapies in Oncology and Hematology? A Willingness-to-Pay Study in BulgariaGeorgi Iskrov, Dan Greenberg, Ivan Yakimov, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Cost-utility analyses of diagnostic laboratory tests: a systematic reviewChiHui Fang, Hansel J Otero, Dan Greenberg, et al.
Health Policy (Amsterdam, Netherlands)|September 15, 2004
Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation studyDan Greenberg, Ameet Bakhai, Peter J Neumann, et al.
Angiology|February 28, 2020
Early Atrial Fibrillation During Acute Myocardial Infarction May Not Be an Indication for Long-Term AnticoagulationMichal Axelrod, Harel Gilutz, Ygal Plakht, et al.
ESC Heart Failure|November 8, 2021
The impact of a community-based heart failure multidisciplinary team clinic on healthcare utilization and costsJean Marc Weinstein, Dan Greenberg, Amir Sharf, et al.
Pageof 15